Ping An Biomedical Co., Ltd. PASW
4.96 USD +0.28 (+5.98%)
Nov 3, 2026, 3:51 PM EST
4.25 Day range 5.10
3.07 52-week range 28.56
- YTD
- -75.30%
- 1 year
- -82.29%
Financial health
Altman Z-Score
3.01 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -12.8×
FY 2021 5y median -12.8× FY 2025
P/S 4.8×
FY 2021 5y median 1.7× FY 2025
P/B 3.6×
FY 2021 5y median -20.7× FY 2025
P/FCF -25.4×
FY 2021 5y median -3.3× FY 2025
EV/EBITDA -12.0×
FY 2021 5y median 18.4× FY 2025
EV/Sales 5.0×
FY 2021 5y median 1.8× FY 2025
FCF Yield -3.9%
FY 2021 5y median -3.4% FY 2025
Profitability
Gross Margin 2.8%
FY 2021 5y median 6.2% FY 2025
Operating Margin -43.1%
FY 2021 5y median 0.7% FY 2025
Net Margin -37.6%
FY 2021 5y median -1.2% FY 2025
ROE -28.4%
FY 2021 5y median 17.0% FY 2025
ROIC -23.1%
FY 2021 5y median -0.1% FY 2025
ROA -18.8%
FY 2021 5y median -1.2% FY 2025
Growth (YoY)
Revenue -61.0%
FY 2021 FY 2025
Operating Income -720913.7%
FY 2021 FY 2025
EPS (diluted) -867.7%
FY 2021 FY 2025
Free Cash Flow -143.9%
FY 2021 FY 2025
Financial Health
Current Ratio 2.8×
FY 2021 5y median 0.9× FY 2025
Quick Ratio 2.7×
FY 2021 5y median 0.9× FY 2025
Debt / Equity 0.2×
FY 2021 5y median -1.5× FY 2025
Net Debt / EBITDA -0.6×
FY 2021 5y median 3.1× FY 2025
Interest Coverage -47.9×
FY 2021 5y median 0.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.2% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30